Download full report with analyst certification and important disclosures
Jan 14 2022, 07:05 GMT
Uniphar
Revising estimates and price target to reflect recent M&A
- Sectors : Pharma and healthcare
- Companies : Uniphar
DAVY VIEW
We are upgrading our 2022 and 2023 EPS by 3% to reflect the acquisitions of E4H, Devonshire and Navi announced by Uniphar on December 23rd. We are also raising our price target to €5.0 based on our revised sum-of-the-parts (SoTP) valuation. Next update is the FY prelims on January 26th.
